Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
4.100
+0.020 (0.49%)
At close: Jun 26, 2026, 4:00 PM EDT
4.150
+0.050 (1.22%)
After-hours: Jun 26, 2026, 6:33 PM EDT
Intensity Therapeutics Employees
As of December 31, 2025, Intensity Therapeutics had 7 total employees, including 5 full-time and 2 part-time employees. The number of employees did not change compared to the previous year.
Employees
7
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,527,571
Market Cap
11.08M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7 | 0 | - |
| Dec 31, 2024 | 7 | 0 | - |
| Dec 31, 2023 | 7 | 1 | 16.67% |
| Dec 31, 2021 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CytoMed Therapeutics | 42 |
| OSR Health | 22 |
| Jasper Therapeutics | 22 |
| Theriva Biologics | 16 |
| CalciMedica | 16 |
| Kiora Pharmaceuticals | 13 |
| Psyence Biomedical | 12 |
| Akari Therapeutics, | 6 |
INTS News
- 11 days ago - Intensity Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award - PRNewsWire
- 7 weeks ago - Intensity Therapeutics reports Q1 EPS (96c), consensus ($1.09) - TheFly
- 7 weeks ago - Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update - PRNewsWire
- 7 weeks ago - Intensity Therapeutics Quarterly report: Q1 2026 - Filings
- 7 weeks ago - Intensity Therapeutics Earnings release: Q1 2026 - Filings
- 2 months ago - Intensity Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Intensity Therapeutics Proxy statement: Proxy filing - Filings